GC
CHNG

Greenlight Capital’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Greenlight Capital’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-801,701
Closed -$22M – 47
2022
Q3 		$22M Sell
801,701
-665,174
-45% -$16.5M 1.56% 16
2022
Q2 		$33.8M Sell
1,466,875
-2,278,830
-61% -$53.2M 2.63% 11
2022
Q1 		$81.7M Buy
3,745,705
+108,900
+3% +$2.26M 5.19% 4
2021
Q4 		$77.8M Buy
3,636,805
+50,000
+1% +$1.05M 4.45% 5
2021
Q3 		$75.1M Buy
3,586,805
+135,660
+4% +$2.96M 5.04% 5
2021
Q2 		$79.5M Hold
3,451,145
– – 4.99% 6
2021
Q1 		$76.3M Sell
3,451,145
-1,391,860
-29% -$32.2M 5.31% 5
2020
Q4 		$90.3M Sell
4,843,005
-450,500
-9% -$7.4M 5.43% 5
2020
Q3 		$76.8M Sell
5,293,505
-64,700
-1% -$823K 6.27% 4
2020
Q2 		$60M Buy
5,358,205
+64,200
+1% +$721K 6.51% 6
2020
Q1 		$52.9M Buy
+5,294,005
New +$74M 7.53% 4

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Greenlight Capital's CHNG Position: Q4 2022 in Review

Greenlight Capital sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 801,701 shares — an estimated $22M sold.

Greenlight Capital first reported a position in CHNG in Q1 2020 and held it in 11 quarters. The position peaked at $90.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Greenlight Capital reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Greenlight Capital sold 801,701 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $22M.
  • Greenlight Capital first reported a position in Change Healthcare Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Greenlight Capital's Change Healthcare Inc. Common Stock position peaked at $90.3M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Greenlight Capital's 13F filing for Q4 2022, filed 14 Feb 2023.